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OBJECTIVES We sought to determine the role of preoperative predictors, particularly ischemia, on
preoperative thallium scanning (PTS) and coronary revascularization on low-level and
conventional troponin elevations after major vascular surgery.
BACKGROUND Postoperative cardiac troponin (cTn) elevations have recently been shown to predict both
short- and long-term mortality after vascular surgery.
METHODS The perioperative data, including PTS and subsequent coronary revascularization, continuous
perioperative 12-lead ST-segment trend monitoring, cTn-I and/or cTn-T, and creatine
kinase-MB fraction in the first three postoperative days, were prospectively collected in 501
consecutive elective major vascular procedures.
RESULTS Moderate to severe inducible ischemia on PTS was associated with a 49.0% incidence of
low-level (cTn-I 0.6 and/or cTn-T 0.03 ng/ml) and 22.4% conventional (cTn-I 1.5
and/or cTn-T 0.1 ng/ml) troponin elevation. In contrast, patients with preoperative
coronary revascularization had 23.4% and 6.4% low-level and conventional troponin eleva-
tions, respectively, similar to patients without ischemia on PTS. By multivariate logistic
regression, ischemia on PTS was the most important predictor of both low-level and
conventional troponin elevations (adjusted odds ratios [ORs] 2.5 and 2.7, p  0.02 and 0.04,
respectively), whereas preoperative coronary revascularization predicted less troponin eleva-
tions (adjusted ORs 0.35 and 0.16, p 0.045 and 0.022, respectively). Postoperative ischemia
(10 min), the more so prolonged (30 min) ischemia was the only independent predictor
of troponin elevation if added with the preoperative predictors to the multivariate analysis
(ORs 15.8 and 22.8, respectively; p  0.001).
CONCLUSIONS Troponin elevations occur frequently after vascular surgery. They are strongly associated with
postoperative ischemia, predicted by inducible ischemia on PTS, and reduced by preoperative
coronary revascularization. (J Am Coll Cardiol 2004;44:569–75) © 2004 by the American
College of Cardiology FoundationM
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Pardiac-specific troponins are powerful and independent
redictors of prognosis in patients with acute coronary
yndromes (1,2). Previous studies have shown that among
atients with unstable angina and non–ST-segment eleva-
ion type infarction, even the smallest increases in cardiac
roponin (cTn)-I or -T are associated with a worse outcome
3). This led to a shift in the current diagnostic definitions
See page 576
f myocardial infarction (MI), and a greater emphasis is
ow given to the rise and fall of biochemical markers, in
articular, cardiac troponins (4), especially regarding non–
T-segment elevation MI. The diagnosis of postoperative
From the Departments of *Anesthesiology and CCM, †Cardiology, ‡Vascular
urgery, §Nuclear Medicine, and Clinical Biochemistry, The Hebrew University and
adassah Medical Center, Jerusalem, Israel.
Manuscript received January 16, 2004; revised manuscript received March 8, 2004,vccepted March 11, 2004.I is even more dependent on cardiac troponin elevations
ecause of its silent nature, the associated subtle and
ransient ST-segment depression type ischemic changes (5),
nd the relatively low specificity of creatine kinase-MB
raction (CK-MB) (6).
We have recently reported that even minor elevations in
ostoperative serum troponin concentration, below the con-
entional cut-off level for the diagnosis of MI, are associated
ith significantly worse long-term survival after major
ascular surgery (7). That study was accompanied by a call
or a further in-depth analysis of the etiology and population
t risk of low-level postoperative troponin elevation (8).
nducible ischemia on preoperative thallium scanning
PTS) predicts adverse postoperative and long-term cardiac
vents. It has also been recently shown that significant
schemia on PTS is an independent predictor of long-term
ortality after major vascular surgery and that coronary
evascularization in patients with significant ischemia on
hallium scanning is associated with improved long-term
urvival (9). The effects of preoperative factors, in particular,
TS findings and coronary revascularization, on low-level
ersus conventional postoperative troponin elevation after
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ated.
ETHODS
fter approval by the institutional review board and in-
ormed consent, 501 consecutive elective major vascular
urgical procedures performed in 447 patients at the
adassah University Hospital from July 1997 to June 2001
ere prospectively studied. This group has been described
reviously (5). Patients with an unstable coronary syndrome
n the three months preceding surgery were excluded. All
reoperative long-term cardiovascular medications, includ-
ng beta-blockers and aspirin, were continued until the day
f surgery and resumed as soon as possible postoperatively.
fter completion of surgery, patients were treated in the
ecovery room or intensive care unit until at least the
orning after surgery and had intra-arterial blood pressure
onitoring and continuous 12-lead ST-segment trend
onitoring. The preoperative clinical findings and periop-
rative cardiac complications were recorded.
Preoperative thallium scanning was routinely performed
n patients scheduled for aortic surgery or lower extremity
ypass. Patients scheduled for carotid endarterectomy un-
erwent thallium scanning according to the American
ollege of Cardiology/American Heart Association (ACC/
HA) practice guidelines (10). Patients did not undergo
TS if they had had coronary angiography within the year
efore surgery with no subsequent change in symptoms, a
egative exercise stress test with no history of coronary
rtery disease (CAD), and no clinical evidence or history of
AD and a delay of the vascular surgery was perceived to be
etrimental in terms of their leg ischemia.
Our protocol for PTS has been published previously (8).
n brief, thallium defects were defined as either fixed or
eversible. The defect size was determined based on a
ine-sector model of the heart. A defect larger than two
ectors was defined as large, one or two sectors as moderate,
nd less than one as small. Defect severity was evaluated
ased on the ratio of defect intensity to presumed normal
yocardial area: mild defect  a reduction of 15% to 40%
n counts; moderate  reduction of 40% to 50%; and severe
50% reduction in counts (11). Patients with moderate
r severe reversible defects, including partially reversible, or
arge areas (2 sectors) of even mild but reversible defects
Abbreviations and Acronyms
CABG  coronary artery bypass graft surgery
CAD  coronary artery disease
CK-MB  creatine kinase-MB fraction
cTn  cardiac troponin
MI  myocardial infarction
OR  odds ratio
PCI  percutaneous coronary intervention
PTS  preoperative thallium scanningn thallium imaging were defined as “moderate to severe deversible ischemia” and were referred to coronary angiog-
aphy and possible revascularization by either percutaneous
oronary intervention (PCI) or coronary artery bypass graft
urgery (CABG) before vascular surgery. Preoperative PCI
as performed for technically accessible, 70% coronary
tenosis. The CABG was preferred in patients with signif-
cant (50%) left main coronary stenosis, diabetic patients
ith multivessel disease, or patients with two- or three-
essel disease unsuitable for PCI.
Continuous 12-lead electrocardiographic (ECG) moni-
oring has been described previously (4). In brief, before
nduction of anesthesia, patients were connected to a con-
inuous 12-lead ECG monitor (Solar 7000, Marquette
lectronics, Milwaukee, Wisconsin) and a Cardiac Review
tation (ST-Guard, Marquette Electronics). Monitoring
as continued for at least 48 h and up to 72 h. Episodes of
T-segment deviation, defined as ST-segment depression
r elevation of 0.2 mV in one lead or 0.1 mV in two
ontiguous leads that lasted more than 10 min, were
utomatically detected and marked by the ST-Guard. The
T-segment deviations lasting10 min were ignored. Each
atient’s longest and cumulative ischemia duration, as well
s the number of ischemic events, was recorded.
iochemical markers of MI. Cardiac troponin I and/or T
nd CK-MB were measured in all patients immediately after
urgery and every morning for the first three postoperative
ays. If either one of these markers was elevated, its measure-
ent was continued for the next days until its return to normal
alues. Until January 1999, only cTn-I was available in our
nstitution. From January 1999, cTn-T served as the primary
ndicator for MI, whereas cTn-I was used only for confirma-
ion in patients with impaired renal function exhibiting high
evels of cTn-T. Troponin I was measured using a Stratus II
nalyzer (Dade-Behring Inc., Marburg, Germany). Troponin
was measured by the Elecsys 2010 system (Boehringer
annheim Corp., GmBH, Germany). Two different cut-off
evels for cardiac troponins were examined: 1) cTn-I 1.5
nd/or cTn-T 0.1 ng/ml. These were the receiver operating
haracteristic curve medical decision cut-offs for MI defined by
he manufacturers of these assays. 2) A cTn-I 0.6 and/or
Tn-T 0.03 ng/ml, corresponding to the lowest troponin
evels with 10% imprecision or coefficient variation for these
ssays (12).
The CK level was measured by a Vitros dry chemistry
nalyzer (Ortho Clinical Diagnostics, Johnson & Johnson,
aritan, New Jersey). The upper limit of normal for CK was
70 IU. Two cut-off levels for CK-MB/total CK were
xamined: 5% and 10%.
Clinical MI was diagnosed by the treating physicians,
ndependent of this study, if cTn-I 1.5 and/or cTn-T 0.1
g/ml was associated with at least one of the following: typical
schemic symptoms, ECG changes indicative of ischemia, or
ew pathologic Q waves.
tatistical analyses. The t test was used for continuous
ariables, and the chi-square test was used to compare
ichotomous variables between groups of patients. Univar-
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August 4, 2004:569–75 Predictors of Troponin After Vascular Surgeryate and multivariate logistic regression analyses were used
o find an association between preoperative and postopera-
ive variables, and a stepwise backward conditional selection
ethod was used to select the independent predictors of
ostoperative markers and calculate odds ratios (ORs) and
5% confidence intervals. A p value of 0.05 was consid-
red statistically significant. All the analyses were performed
sing SPSS version 11.0 (SPSS Inc., Chicago, Illinois).
able 1. Preoperative Demographic and Clinical Data
All Vascular
Procedures
(n  501)
ge (yrs) 68  10
ender (male/female) 349/152 (69.7/30.3)
urgery
Carotid endarterectomy 231 (46.1)
Abdominal aortic surgery 77 (15.4)
Infra-inguinal bypass procedure 193 (38.5)
iabetes mellitus 125 (24.9)
ypertension 320 (63.9)
yperlipidemia 154 (30.7)
moking history 279 (55.7)
istory of IHD 206 (41.1)
Status after MI 131 (26.1)
Angina pectoris 76 (17.0)
Congestive heart failure 38 (7.6)
idney disease, creatinine 2 mg/dl 13 (2.9)
reoperative thallium scanning 295 (58.9)
Moderate-severe reversible defects 96 (19.2)
Moderate-severe fixed defects 56 (11.2)
reoperative coronary angiography 73 (14.6)
reoperative PTCA/CABG 58 (11.6)
Prior PTCA (any time in the past) 83 (16.6)
Prior CABG (any time in the past) 99 (19.8)
edications
Beta-blockers 197 (39.3)
Calcium channel blockers 239 (47.7)
ACE inhibitors 243 (48.5)
Diuretics 134 (26.7)
Hypolipidemic agents 151 (30.1)
ata are presented as the mean value  SD or number (%) of subjects.
ACE  angiotensin-converting enzyme; CABG  coronary artery bypass graft
urgery; IHD ischemic heart disease; PTCA percutaneous transluminal coronary
ngioplasty; MI  myocardial infarction.
able 2. Association of Preoperative Thalium and Coronary Reva
cTn-I >0.6
and/or cTn-T
>0.03 ng/ml
cTn
and/o
>0.1
ll patients (N  501) 116 (23.1) 45
o moderate-severe reversible defects 52 (26.1) 19
ith moderate-severe reversible defects 36 (37.5) 14
p value 0.032 0
o moderate-severe fixed defects 66 (28.4) 25
ith moderate-severe fixed defects 21 (37.5) 7
p value 0.12 0
ith moderate-severe reversible defects but
no coronary revascularization
24 (49.0) 11
ith preoperative coronary revascularization
(CABG/PTCA)
11 (23.4) 3
p value 0.015 0
ata are presented as the number (%) of subjects. Boldface indicates statistically sig
CK-MB  creatine kinase-MB fraction; cTn  cardiac troponin; other abbreviations aESULTS
he demographic and preoperative clinical findings are sum-
arized in Table 1. Preoperative thallium scanning was per-
ormed before 295 (58.9%) of the vascular procedures, and
oderate to severe ischemia was observed in 96 (32.5%) of
hem. Fifty-eight (11.6%) vascular procedures were preceded
y PCI (n 43) or CABG (n 15) in the year before vascular
urgery, and in 47 (81.0%) of them, coronary revascularization
as performed as a result of the preoperative thallium findings
PCI in 35 patients and CABG in 12 patients). The time from
CI to surgery was 84  78 days (range 1 to 329 days) and
etween CABG and surgery 112  105 days (range 7 to 302
ays). In nine patients, PCI with an intracoronary stent was
erformed, and the shortest duration between coronary stent-
ng and vascular surgery was 21 days.
During 25,622 patient-hours of continuous 12-lead ECG
onitoring (51.4  15.7 h/patient), 69 patients had 108
ransient ischemic episodes (10 min), and all episodes
xcept for one were characterized by ST-segment depres-
ion. In 44 (8.7%) of the procedures, the longest ischemic
pisode lasted 30 min, and in 23 (4.6%), ischemia lasted
60 min.
yocardial infarction. Depending on the biochemical
arker and the threshold level used to define MI, between 14
2.8%) and 116 (23.1%) of all 501 procedures were complicated
y postoperative MI (Table 2). Using the lower cut-off level of
roponin (cTn-I 0.6 and/or cTn-T 0.03 ng/ml), 23.1%
ad postoperative MI, as compared with only 9% if the
onventional cut-off levels (cTn-I 0.6 and/or cTn-T ng/ml
0.03) were used. Similarly, if CK-MB 5% was used, 7.4%
f the procedures were complicated by postoperative MI, as
ompared with 2.8% if the threshold of CK-MB 10% was
tilized. Symptoms attributable to infarction, such as pro-
onged chest pain, congestive heart failure, or new-onset
rrhythmia, were recorded in only 18 (3.6%) of the patients.
one of the patients had new Q waves. Patients who had
oderate to severe ischemia on PTS had higher incidences of
Tn-I 0.6 and/or cTn-T 0.03 ng/ml (37.5%), CK-MB
rization With Postoperative Ischemia and Infarction
.5
-T
ml
CK-MB
>5%
CK-MB
>10%
Ischemia
>10 min
Ischemia
>30 min
Clinically
Diagnosed
MI
37 (7.4) 14 (2.8) 81 (1.2) 44 (8.8) 16 (3.2)
13 (6.5) 3 (1.5) 31 (15.6) 15 (7.5) 5 (2.5)
) 12 (12.5) 5 (5.2) 30 (31.2) 15 (15.6) 9 (9.4)
0.069 0.07 0.021 0.028 <0.001
) 16 (6.9) 5 (2.2) 39 (16.3) 19 (8.2) 10 (4.2)
) 8 (14.3) 2 (3.6) 19 (33.9) 8 (14.3) 4 (7.1)
0.069 0.41 0.049 0.13 0.06
) 8 (16.3) 3 (6.1) 16 (32.7) 14 (28.6) 9 (9.4)
4 (8.5) 2 (4.3) 4 (8.5) 1 (2.1) 0
0.19 0.52 0.003 <0.001 0.001
t values (0.05).scula
-I >1
r cTn
ng/
(9.0)
(9.5)
(14.6
.14
(10.8
(12.5
.43
(22.4
(6.4)
.024
nifican
s in Table 1.
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han patients without such thallium results (Table 2). Among
atients with moderate to severe ischemia on thallium scan-
ing, those without preoperative coronary revascularization
ad the highest incidences of low-level troponin elevation
49%), CK-MB 5% (22.4%), and ischemia 10 min
32.7%), significantly higher than in patients with preoperative
oronary revascularization (Table 2).
Myocardial infarction was clinically diagnosed by the
reating physicians in 16 patients (3.2%), based on the
ombination of elevated cardiac troponin levels above the
onventional cut-off levels (cTn-I1.5 and/or cTn-T0.1
g/ml), with ECG findings and/or prolonged chest pain. In
ll but one of these patients, MI was diagnosed already in
he first three postoperative days. The distribution of these
atients according to their preoperative findings is summa-
ized in Table 2. Two of these patients died shortly after
ostoperative infarction (8 and 32 days postoperatively).
redictors of myocardial ischemia and MI. Table 3
hows the univariate logistic regression analysis of all pre-
perative predictors of low-level troponin elevation (cTn-I
0.6 and/or cTn-T 0.03 ng/ml), conventional troponin
levation (cTn-I 1.5 and/or cTn-T 0.1 ng/ml), and
yocardial ischemia (10 min). In this analysis, a history of
schemic heart disease, diabetes mellitus, and moderate to
evere ischemia on PTS were associated with the markers of
able 3. Peoperative Predictors of Postoperative Troponin (Logis
cTn-I >0.6 and/or
cTn-T >0.03 ng/ml
OR (95% CI) p Valu
ge 1.02 (1.00–1.04) 0.039
ender (female vs. male) 0.87 (0.53–1.42) 0.53
urgery
AAS (vs. CEA) 1.26 (0.68–2.33) 0.44
Infra-inguinal (bypass vs. CEA) 1.48 (0.93–2.34) 0.09
iabetes mellitus 1.73 (1.09–2.71) 0.018
ypertension 1.48 (0.95–2.32) 0.082
yperlipidemia 1.06 (0.67–1.68) 0.79
moking history 1.14 (0.72–1.80) 0.56
istory of IHD 1.82 (1.18–2.80) 0.006
S/A MI 1.46 (0.93–2.29) 0.098
Angina pectoris 1.55 (0.88–2.71) 0.28
Congestive heart failure 2.24 (1.13–4.46) 0.021
idney disease, creatinine 2 mg/dl 1.14 (0.37–3.53) 0.81
reoperative thallium scanning
Moderate-severe reversible defects 1.84 (1.08–3.11) 0.024
Moderate-severe fixed defects 1.41 (0.79–2.51) 0.25
reoperative PTCA/CABG 1.19 (0.64–2.19) 0.57
edications
Beta-blockers 0.67 (0.37–1.21) 0.19
Calcium channel blockers 0.87 (0.50–1.49) 0.61
ACE inhibitors 1.27 (0.74–2.17) 0.38
Diuretics 1.15 (0.61–2.18) 0.66
Hypolipidemic agents 0.74 (0.41–1.33) 0.28
oldface indicates statistically significant values (0.05).
AAS  abdominal aortic surgery; CEA  carotid endarterectomy; other abbrevischemia and infarction. A history of congestive heart failure (as associated with elevated postoperative troponin levels,
nd preoperative coronary revascularization was associated
ith less postoperative ischemia on univariate analysis.
Table 4 summarizes only the independent preoperative
redictors of postoperative troponin and ischemia after
tepwise selection by the multivariate logistic regression
odel. Moderate to severe ischemia on thallium scanning
ndependently predicted an increase in troponin (both
hreshold levels) and postoperative ischemia. Conversely,
reoperative coronary revascularization independently pre-
icted fewer troponin elevations (both threshold levels) and
ess postoperative ischemia. It is noteworthy that moderate
o severe ischemia on thallium scanning was the only
ndependent predictor of troponin elevation, even after
xclusion from the analysis of patients with postoperative
roponin above the conventional cut-off levels (cTn-I 1.5
nd/or cTn-T 0.1 ng/ml; adjusted OR 2.53, 95% confi-
ence interval 1.17 to 5.47; p  0.018).
ffect of postoperative ischemia. Both low-level and con-
entional troponin elevations were strongly associated with
ostoperative 10 min ischemia (OR 3.95 and 9.77, p 
.001) and with prolonged (30 min) ischemia (ORs 7.2
nd 24.9, p  0.001). Postoperative (10 min) ischemia
as the only independent predictor of conventional tropo-
in elevation when analyzed with multivariate logistic re-
ression analysis, together with all preoperative predictors
egression Analysis)
Univariate Analysis
cTn-I >1.5 and/or
cTn-T >0.1 ng/ml
ST-Segment Depression Type
Ischemia >10 min
OR (95% CI) p Value OR (95% CI) p Value
1.02 (0.99–1.05) 0.11 1.005 (0.97–1.03) 0.076
0.92 (0.47–1.83) 0.87 0.38 (0.16–0.86) 0.022
1.77 (0.77–4.05) 0.17 2.19 (0.85–5.66) 0.105
1.73 (0.89–3.36) 0.10 2.92 (1.39–6.13) 0.005
1.75 (0.96–3.34) 0.07 2.08 (1.11–3.91) 0.022
1.94 (0.91–4.04) 0.083 1.10 (0.56–2.16) 0.77
0.94 (0.49–1.78) 0.85 1.23 (0.63–2.38) 0.53
1.25 (0.68–2.31) 0.46 1.16 (0.62–2.18) 0.63
1.74 (1.02–3.03) 0.048 1.97 (1.06–3.67) 0.032
1.05 (0.55–2.00) 0.87 1.23 (0.64–2.35) 0.52
1.42 (0.66–3.02) 0.36 1.69 (0.80–3.53) 0.16
1.19 (0.37–3.24) 0.87 1.33 (0.31–2.77) 0.91
1.24 (0.23–4.63) 0.74 1.56 (0.24–14.21) 0.56
1.39 (0.67–2.84) 0.37 2.63 (1.25–5.55) 0.011
1.10 (0.49–2.46) 0.80 1.58 (0.69–3.63) 0.27
0.38 (0.11–1.28) 0.12 0.13 (0.02–0.96) 0.046
1.42 (0.66–3.02) 0.36 1.02 (0.46–2.24) 0.95
0.96 (0.46–1.99) 0.91 0.63 (0.28–1.39) 0.25
0.93 (0.45–1.93) 0.85 0.99 (0.46–2.11) 0.98
1.13 (0.48–2.63) 0.77 0.89 (0.35–2.22) 0.81
0.92 (0.55–1.89) 0.88 1.12 (0.40–1.98) 0.67
as in Tables 1 to 3.tic R
eOR 15.8, p  0.001). Only postoperative (10 min)
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August 4, 2004:569–75 Predictors of Troponin After Vascular Surgeryschemia and moderate to severe reversible ischemia on
hallium scanning independently predicted low-level tropo-
in elevation (ORs 4.5 and 2.2, p  0.001 and 0.023,
espectively). Similarly, prolonged (30 min) postoperative
schemia was the only independent predictor of conven-
ional troponin elevation if added with the preoperative
redictors to the multivariate analysis (OR 22.8, p 0.001).
ISCUSSION
ecent studies reported a decreasing incidence of perioper-
tive MI after major vascular surgery. This is also supported
y the present study, where the incidence of clinically
dentified postoperative MI was only 3.2%. However, our
ata further show that this apparently low incidence of
ostoperative MI represents only a small fraction of all
ostoperative myocardial injuries or infarctions. After major
ascular surgery, conventional postoperative troponin eleva-
ions (cTn-I 1.5 and/or cTn-T 0.1 ng/ml) occur in
.0% and low-level troponin elevations (cTn-I 0.6 and/or
Tn-T 0.03 ng/ml) are found in 23.4% of patients, both
f which are associated with worse long-term survival (7).
oreover, the present study shows that patients with
oderate to severe reversible ischemia on PTS have up to a
9.0% incidence of low-level troponin elevations and 22.4%
onventional troponin elevations, except if they undergo
reoperative coronary revascularization. In the latter case,
he incidence of troponin elevation is similar to that of
atients without significant reversible ischemia on PTS
23.4% and 6.4%, respectively) (Table 2). Two major factors
redicted elevated postoperative troponin levels, as well as
ilent ischemia, in our study: the severity of CAD, as
ndicated by the presence of moderate to severe ischemia on
TS, and preoperative coronary revascularization. Moderate
o severe ischemia on thallium scanning was associated with
n up to 2.7-fold increase in the incidence of postoperative
roponin elevation (p 0.02) and an up to 5.0-fold increase
n the incidence of postoperative ischemia (p  0.001). In
ontrast, preoperative coronary revascularization by either
able 4. Peoperative Predictors of Postoperative Troponin as Sel
cTn-I >0.6 and/or
cTn-T >0.03 ng/ml
cTn-I >1.5
cTn-T >0.1
OR
(95% CI)
p
Value
OR
(95% CI)
ge 1.03 (0.99–1.07) 0.060 1.04 (0.99–1.07
ype of surgery
AAS
Infra-inguinal bypass
oderate-severe
reversible defects
2.55 (1.16–5.62) 0.020 2.74 (1.03–7.28
reoperative PTCA/
CABG
0.35 (0.13–0.97) 0.045 0.16 (0.03–0.76
oldface indicates statistically significant values (0.05).
AAS  abdominal aortic surgery; CI  confidence interval; OR  odds ratio; oCI or CABG was associated with a significant reduction, slthough not complete elimination of both the incidence of
roponin elevation and postoperative ischemia (adjusted
Rs 0.35 and 0.19, p  0.045 and 0.006, respectively)
Table 4).
Several studies have demonstrated that inducible isch-
mia on preoperative thallium scanning predicted cardiac
vents after major noncardiac surgery (13–15), although two
tudies disagreed with these results (16,17). A few studies
lso suggested that preoperative coronary revascularization
mproves the cardiac outcome early after major noncardiac
urgery (18,19). We have recently shown that preoperative
oronary revascularization in patients with moderate to
evere reversible ischemia on thallium scanning is associated
ith improved long-term survival after major vascular sur-
ery (9). However, none of the previous studies explored the
ssociation of PTS results or coronary revascularization with
ostoperative cardiac troponin and ischemia duration after
ajor surgery. Furthermore, no previous study has investi-
ated the high incidence of low-level postoperative troponin
levations associated with preoperative CAD. These miss-
ng links to prognosis are provided in the present study.
The importance of the present data is evident in light of
ecent publications that cardiac troponin, per se, after major
oncardiac surgery predicts both short- and long-term
ardiac morbidity and survival. Two studies have shown that
onventional postoperative troponin elevations are associ-
ted with an up to 5.9-fold increase in mortality and cardiac
omplications in the first six months after major noncardiac
urgery (20,21). We have recently demonstrated, in the
ame cohort of patients, that not only conventional but also
inor postoperative troponin elevations predicted a greater
isk of long-term (up to five years) mortality after major
ascular surgery.
Cardiac troponins are sensitive and specific markers of
yocardial injury. Even minor elevations in troponin are
ssociated with a higher risk of death and re-infarction
mong patients with non–ST-segment elevation acute cor-
nary syndromes (22,23). In the setting of acute coronary
by the Multivariate Logistic Regression Analysis
ultivariate Analysis
or
l Ischemia >10 min Ischemia >30 min
p
alue
OR
(95% CI) p Value
OR
(95% CI) p Value
.081
2.85 (1.14–7.11) 0.025
1.80 (0.81–4.00) 0.15
.041 3.88 (2.03–8.74) <0.0001 5.06 (2.06–12.44) <0.0001
.022 0.19 (0.06–0.62) 0.006 0.07 (0.009–0.60) 0.015
breviations as in Table 1.ected
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Predictors of Troponin After Vascular Surgery August 4, 2004:569–75igher incidence of multivessel disease, complex coronary
esions, visible thrombus, distal embolization of platelet
icro-aggregates, and abnormal myocardial tissue level
erfusion (24). However, troponin elevation may also occur
fter apparently minor insults, due to causes other than
cute coronary syndromes (i.e., following prolonged tachy-
ardia with or without hemodynamic compromise), even in
atients without angiographic significant CAD (50%
tenosis) (25), in patients with sepsis (26,27), and after
rolonged strenuous endurance exercise (28). Low-level
erum troponin elevation has been documented in patients
ith chronic heart failure and shown to correlate with
ncreased cardiac filling pressures, serum beta-type natri-
retic peptide, and worse long-term survival (29). The
athophysiology behind serum troponin elevations in heart
ailure is believed to be distinct from that seen in acute
oronary syndromes and most probably results from pro-
ressive myocyte loss through necrotic and apoptotic cell
eath (30,31). Other reports proposed a relationship be-
ween troponin and death in clinical scenarios in which
entricular wall stress is increased, such as massive pulmo-
ary embolism (32), subarachnoid hemorrhage (33), and
cute medical illness requiring intensive care (20). Increased
yocardial wall stress leads to reduced subendocardial
erfusion, even in the absence of CAD, resulting in a
ecline in systolic function (34,35).
Tachycardia, hemodynamic instability, prolonged adren-
rgic stimulation, increased cardiac filling pressures, ventric-
lar wall stress, and heart failure are frequent phenomena
uring and after major surgery. These may potentially lead
o acute coronary events, but also to non–acute-coronary-
vent type postoperative ischemia, troponin elevations, and
ortality (1). As evident from this and previous studies (36),
he overwhelming majority of postoperative cardiac events,
yocardial injuries, and infarctions are preceded by ST-
egment depression rather than ST-segment elevation type
schemia. Prolonged ST-segment depression type ischemia
s the most common precursor of postoperative MI, whereas
T-segment elevation is relatively rare in this setting (5). In
his study, postoperative ischemia was the only independent
redictor of conventional troponin elevation, and together
ith preoperative moderate to severe ischemia on thallium
canning, ischemia independently predicted low-level post-
perative troponin elevation. It is suggestive therefore that
oth low-level and conventional troponin elevations (myo-
ardial injury and infarction) represent a continuum of
vents in which longer duration postoperative stress-
nduced ischemia is associated with a higher troponin
levation (5) and worse survival (7). Based on these findings,
t is also understandable why therapeutic measures to reduce
erioperative stress, such as prophylactic perioperative beta-
drenergic blockade, reduce perioperative and long-term
dverse cardiac events (37,38).
Several important caveats deserve special emphasis in
ight of these data. Not all postoperative cardiac troponin
levations are necessarily related to CAD. Subsequently, notll postoperative cardiac troponin elevations can be totally
liminated by preoperative coronary interventions. More-
ver, even in patients who undergo preoperative coronary
nterventions, revascularization is not always complete be-
ause of technical or anatomic considerations, thus explain-
ng the low yet not negligible incidence of postoperative
roponin elevations in patients with preoperative coronary
evascularization.
onclusions. Low-level postoperative troponin elevations
requently occur after major vascular surgery, especially in
atients with inducible ischemia on preoperative testing,
ho did not undergo coronary revascularization. Preopera-
ive coronary revascularization significantly reduces but does
ot eliminate postoperative troponin elevation. Prolonged
schemia is the most important precursor of postoperative
roponin elevation. Further studies are required to define the
est methods for preventing postoperative troponin
levations.
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